214 related articles for article (PubMed ID: 16786528)
1. Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex.
Baracskay KL; Haroutunian V; Meador-Woodruff JH
Synapse; 2006 Sep; 60(4):271-9. PubMed ID: 16786528
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins.
Bai J; He F; Novikova SI; Undie AS; Dracheva S; Haroutunian V; Lidow MS
Biol Psychiatry; 2004 Sep; 56(6):427-40. PubMed ID: 15364041
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin.
Clinton SM; Ibrahim HM; Frey KA; Davis KL; Haroutunian V; Meador-Woodruff JH
Am J Psychiatry; 2005 Oct; 162(10):1859-71. PubMed ID: 16199832
[TBL] [Abstract][Full Text] [Related]
4. Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia.
Beneyto M; Meador-Woodruff JH
Synapse; 2006 Dec; 60(8):585-98. PubMed ID: 16983646
[TBL] [Abstract][Full Text] [Related]
5. Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia.
Huerta I; McCullumsmith RE; Haroutunian V; Giménez-Amaya JM; Meador-Woodruff JH
Synapse; 2006 Jun; 59(7):394-402. PubMed ID: 16485262
[TBL] [Abstract][Full Text] [Related]
6. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
Weickert CS; Straub RE; McClintock BW; Matsumoto M; Hashimoto R; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234
[TBL] [Abstract][Full Text] [Related]
7. Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs.
Paterson GJ; Ohashi Y; Reynolds GP; Pratt JA; Morris BJ
J Psychopharmacol; 2006 Sep; 20(5):636-42. PubMed ID: 16478754
[TBL] [Abstract][Full Text] [Related]
8. Enriched environment increases spinophilin mRNA expression and spinophilin immunoreactive dendritic spines in hippocampus and cortex.
Hu XL; Bergström SA; Brink M; Rönnbäck A; Dahlqvist P
Neurosci Lett; 2010 May; 476(2):79-83. PubMed ID: 20385205
[TBL] [Abstract][Full Text] [Related]
9. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
Pantazopoulos H; Stone D; Walsh J; Benes FM
Synapse; 2004 Dec; 54(3):147-55. PubMed ID: 15452863
[TBL] [Abstract][Full Text] [Related]
10. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics.
Dracheva S; McGurk SR; Haroutunian V
J Neurosci Res; 2005 Mar; 79(6):868-78. PubMed ID: 15696539
[TBL] [Abstract][Full Text] [Related]
11. Postnatal alterations in dopaminergic markers in the human prefrontal cortex.
Weickert CS; Webster MJ; Gondipalli P; Rothmond D; Fatula RJ; Herman MM; Kleinman JE; Akil M
Neuroscience; 2007 Feb; 144(3):1109-19. PubMed ID: 17123740
[TBL] [Abstract][Full Text] [Related]
12. Calcyon transcript expression in macaque brain.
Oakman SA; Meador-Woodruff JH
J Comp Neurol; 2004 Jan; 468(2):264-76. PubMed ID: 14648684
[TBL] [Abstract][Full Text] [Related]
13. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development.
Halim ND; Weickert CS; McClintock BW; Hyde TM; Weinberger DR; Kleinman JE; Lipska BK
Mol Psychiatry; 2003 Sep; 8(9):797-810. PubMed ID: 12931207
[TBL] [Abstract][Full Text] [Related]
15. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 12A shows reduced expression in the prefrontal cortex of subjects with schizophrenia.
Pongrac JL; Middleton FA; Peng L; Lewis DA; Levitt P; Mirnics K
Biol Psychiatry; 2004 Dec; 56(12):943-50. PubMed ID: 15601604
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.
Gurevich EV; Joyce JN
Biol Psychiatry; 1997 Oct; 42(7):529-45. PubMed ID: 9376449
[TBL] [Abstract][Full Text] [Related]
18. Dopamine modulation of prefrontal cortex interneurons occurs independently of DARPP-32.
Trantham-Davidson H; Kröner S; Seamans JK
Cereb Cortex; 2008 Apr; 18(4):951-8. PubMed ID: 17693396
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
[TBL] [Abstract][Full Text] [Related]
20. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia.
Kunii Y; Yabe H; Wada A; Yang Q; Nishiura K; Niwa S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1139-43. PubMed ID: 21453742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
